CONMED Corporation

Equities

CNMD

US2074101013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-25 pm EDT			5-day change	1st Jan Change
61.9 ^USD	-11.58%		-12.92%	-43.48%

Apr. 25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
Apr. 25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

CONMED Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022

May 04, 2022 at 04:26 pm EDT

CONMED Corporation reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 242.33 million compared to USD 232.68 million a year ago. Net income was USD 14.98 million compared to USD 9.86 million a year ago. Basic earnings per share from continuing operations was USD 0.51 compared to USD 0.34 a year ago. Diluted earnings per share from continuing operations was USD 0.47 compared to USD 0.31 a year ago.

Latest news about CONMED Corporation

Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	Apr. 25	MT
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	Apr. 25	MT
Transcript : CONMED Corporation, Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Earnings Flash (CNMD) CONMED CORPORATION Posts Q1 Revenue $312.3M, vs. Street Est of $306.7M	Apr. 24	MT
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer	Apr. 24	CI
CONMED Corporation Revises Earnings Guidance for the Full Year 2024	Apr. 24	CI
CONMED Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
CONMED Corporation Announces Not Stand for Re-Election of Jerome Lande as Director	Apr. 08	CI
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024	Feb. 27	CI
Sector Update: Health Care Stocks Rise in Late Afternoon	Feb. 01	MT
CONMED Shares Fall After Q4 Results Trail Analyst Estimates	Feb. 01	MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	Feb. 01	MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	Feb. 01	MT
CONMED Q4 Adjusted Earnings, Net Sales Rise; Sets 2024 Outlook; Shares Drop	Jan. 31	MT
Transcript : CONMED Corporation, Q4 2023 Earnings Call, Jan 31, 2024	Jan. 31
CONMED Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 31	CI
Earnings Flash (CNMD) CONMED CORPORATION Posts Q4 Revenue $327M, vs. Street Est of $332.2M	Jan. 31	MT
CONMED Corporation Provides Financial Guidance for the Full Year 2024	Jan. 31	CI
CONMED Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 31	CI
Transcript : CONMED Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:15 PM	Jan. 08
Conmed Insider Sold Shares Worth $252,833, According to a Recent SEC Filing	Dec. 06	MT
CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable Jan. 5 to Shareholders of Record Dec. 18	Dec. 05	MT
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024	Dec. 05	CI
Conmed Insider Sold Shares Worth $122,874, According to a Recent SEC Filing	Nov. 09	MT
Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating	23-10-27	MT

Chart CONMED Corporation

Duration

Period

More charts

Company Profile

CONMED Corporation is a medical technology company, which provides surgical devices and equipment for minimally invasive procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-23 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for CONMED Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

61.9 USD

Average target price

100.5 USD

Spread / Average Target

+62.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CONMED CORPORATION	-43.48%	1.91B
ABBOTT LABORATORIES	-2.92%	185B
MEDTRONIC PLC	-3.80%	105B
BECTON, DICKINSON AND COMPANY	-5.48%	66.59B
DEXCOM, INC.	+11.22%	54.66B
CENCORA, INC.	+16.74%	47.78B
HOYA CORPORATION	+3.52%	41.26B
WEST PHARMACEUTICAL SERVICES, INC.	+4.56%	26.95B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.64%	26.37B
TERUMO CORPORATION	+13.05%	24.8B

Other Medical Equipment, Supplies & Distribution